Nail Science

Hazard and risk: why the words are different

Articles saved on this device
Flasks with yellow and red liquids beside a clear glass beaker.
Thematic photograph. MART PRODUCTION / Pexels · Pexels licence

A hazard is something with the potential to cause harm. Risk concerns the likelihood of harm under specified circumstances. Identifying a hazard and assessing risk are related tasks, but the first does not supply all the information needed for the second. [1]

KEY TAKEAWAYS

  • Hazard describes a potential for harm. [1]
  • Risk depends on the circumstances being assessed. [1]
  • Our reading: A hazard label alone is not a complete risk assessment.

Potential versus circumstances

EFSA’s glossary distinguishes hazard from risk in its food-safety terminology. The distinction is useful for understanding general scientific language: a potential for harm is different from a conclusion about likelihood in a particular situation. Applying those words to nail materials does not turn the glossary into an assessment of a specific ingredient. [1]

Irritation, sensitisation and allergic reaction

Irritant contact dermatitis results from damage to the skin barrier when irritants injure it faster than it can repair itself. Sensitisation is different: the immune system develops a specific response to an allergen. Subsequent contact can then trigger allergic contact dermatitis, a delayed immune reaction. DermNet notes that irritant and allergic dermatitis can coexist, so appearance alone does not reliably distinguish them. [2][3]

HEMA illustrates sensitisation in nail-product chemistry. Regulation 2020/1682 identifies HEMA and Di-HEMA as sensitisers and links foreseeable skin contamination to sensitisation risk. Its professional-use and allergy-warning requirements are restrictions, not a promise that professionals cannot develop an allergy. [4]

DermNet explains that acrylate allergy is investigated through medical patch testing. Applying uncured gel or a monomer directly to skin as a home test can itself cause sensitisation; it is not an alternative diagnostic method. “HEMA-free” or “TPO-free” identifies an ingredient claim, not an allergy diagnosis, immunity to all ingredients or permission to ignore product precautions. [5]

What a risk statement needs

A meaningful risk statement identifies the situation it addresses. Exposure information is relevant, alongside the nature of the hazard and the scope of the assessment. A bare “high” or “low” without that context hides what was considered. This explanation does not assign categories, thresholds or acceptable levels to salon activities. [1]

Reading confident claims

Our reading: “Hazardous”, “low risk” and “safe” do not communicate the same information. Before treating a claim as evidence, identify its subject, context and source. Hazard and exposure are not combined here into a universal numerical formula. Product-specific decisions need the relevant assessment and documentation, not an interpretation based only on a reassuring adjective.

Article Sources

  1. European Food Safety Authority — hazard

    Primary source

    Glossary description and context: potential harm versus probability under exposure conditions. Food-safety reference used for the conceptual distinction only.

  2. DermNet — Irritant contact dermatitis

    Expert reference material

    Definition and Causes: skin-barrier injury, damage versus repair and exposure conditions; Diagnosis: irritant and allergic dermatitis can coexist.

  3. DermNet — Allergic contact dermatitis

    Expert reference material

    Causes: delayed type IV immune response and sensitisation to a specific allergen; Clinical features and Diagnosis. Page review is labelled August 2025, not a publication day.

  4. European Commission / EUR-Lex — Commission Regulation (EU) 2020/1682 of 12 November 2020

    Regulatory source

    Recitals 4 and 7–12; Annex III entry 313: HEMA, CAS 868-77-9; entry 314: DI-HEMA TRIMETHYLHEXYL DICARBAMATE, CAS 41137-60-4/72869-86-4. Both entries require professional use and an allergy warning, without stating a concentration ceiling. Annex footnotes set 3 June 2021 for placement and 3 September 2021 for availability on the market.

    Adopted:

  5. DermNet — Allergy to acrylates

    Expert reference material

    Who is at risk? Am I allergic? Medical patch tests diagnose acrylate allergy; deliberate skin application of monomers may sensitise. No home-test protocol reproduced.

Written and reviewed with AI assistance using the linked sources. No hands-on product testing or independent specialist review was performed.